文献速递生殖医学

通过测量卵巢刺激开始时的血清LH预测GnRH激动剂触发后的次优卵母细胞获取率

Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.
PubMed 文献 · Hum Reprod · 2019-01-01

该回顾性队列研究纳入2011至2017年在本中心接受GnRH拮抗剂方案并使用曲普瑞林0.2 mg触发排卵的3334例患者,发现卵巢刺激开始时的LH水平是GnRH激动剂触发后次优卵母细胞获取率的独立预测因素,LH<0.1 IU/l者次优风险为45.2%,且风险随基础LH升高而降低。

要点

  • 卵巢刺激开始时的LH水平是GnRH激动剂触发后次优卵母细胞获取的独立预测因素(校正OR 0.920,95%CI 0.871-0.971)。
  • 刺激开始时LH<0.1 IU/l者次优风险45.2%,<0.5、<2、<5 IU/l者风险分别为39.1%、25.2%、13.6%。
  • 作者建议在卵巢刺激开始前测量LH,若不可测则预期次优反应并采取个体化方案。

核心结论

  • 卵巢刺激开始时的LH水平是GnRH激动剂触发后次优卵母细胞获取率的独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2011至2017年在本中心接受GnRH拮抗剂方案并使用曲普瑞林0.2 mg触发最终卵母细胞成熟的所有患者(n=3334)。
  • 主要结局为卵母细胞获取率,定义为获取卵母细胞总数与GnRH激动剂触发前平均直径>10 mm卵泡数的比值。
  • 次优反应定义为卵母细胞获取率低于第10百分位数。
  • 采用多变量回归分析校正女性年龄、体重指数、治疗前口服避孕药、基础及触发日雌二醇水平、起始FSH水平、使用高纯度人绝经期促性腺激素及总促性腺激素剂量。

主要发现

  • 平均年龄31.9岁,平均卵母细胞获取率89%。
  • 次优反应截断值(第10百分位数)为45%,340例患者表现出次优反应。
  • 校正混杂因素后,卵巢刺激开始时的LH水平仍为次优反应的独立预测因素(校正OR 0.920,95%CI 0.871-0.971)。
  • 刺激开始时LH不可测(<0.1 IU/l)者次优风险为45.2%,基础LH<0.5 IU/l、<2 IU/l和<5 IU/l者风险分别为39.1%、25.2%和13.6%。

临床怎么用

  • 作者认为应在卵巢刺激开始前测量LH值。
  • 作者认为若LH值不可测,可预期GnRH激动剂触发后出现次优反应,并需要采取个体化方案。

局限性

  • 本研究的主要局限性是回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are the LH levels at the start of ovarian stimulation predictive of suboptimal oocyte yield from GnRH agonist triggering in GnRH antagonist down-regulated cycles? SUMMARY ANSWER: LH levels at the start of ovarian stimulation are an independent predictor of suboptimal oocyte yield following a GnRH agonist trigger. WHAT IS KNOWN ALREADY: A GnRH agonist ovulation trigger may result in an inadequate oocyte yield in a small subset of patients. This failure can range from empty follicle syndrome to the retrieval of much fewer oocytes than expected. Suboptimal response to a GnRH agonist trigger has been defined as the presence of circulating LH levels <15 IU/l 12 h after triggering. It has been shown that patients with immeasurable LH levels on trigger day have an up to 25% risk of suboptimal response. STUDY DESIGN, SIZE, DURATION: In this retrospective cohort study, all patients (n = 3334) who received GnRH agonist triggering (using Triptoreline 0.2 mg) for final oocyte maturation undergoing a GnRH antagonist cycle in our centre from 2011 to 2017 were included. The primary outcome of the study was oocyte yield, defined as the ratio between the total number of collected oocytes and the number of follicles with a mean diameter >10 mm prior to GnRH agonist trigger. PARTICIPANTS/MATERIALS, SETTING, METHODS: The endocrine profile of all patients was studied at initiation as well as at the end of ovarian stimulation. In order to evaluate whether LH levels, not only at the end but also at the start, of ovarian stimulation predicted oocyte yield, we performed multivariable regression analysis adjusting for the following confounding factors: female age, body mass index, oral contraceptives before treatment, basal and trigger day estradiol levels, starting FSH levels, use of highly purified human menopausal gonadotrophin and total gonadotropin dose. Suboptimal response to GnRH agonist trigger was defined as <10th percentile of oocyte yield. MAIN RESULTS AND THE ROLE OF CHANCE: The average age was 31.9 years, and the mean oocyte yield was 89%. The suboptimal response to GnRH agonist trigger cut-off (<10th percentile) was 45%, which was exhibited by 340 patients. Following confounder adjustment, multivariable regression analysis showed that LH levels at the initiation of ovarian stimulation remained an independent predictor of suboptimal response even in the multivariable model (adjusted OR 0.920, 95% CI 0.871-0.971). Patients with immeasurable LH levels at the start of stimulation (<0.1 IU/l) had a 45.2% risk of suboptimal response, while the risk decreased with increasing basal LH levels; baseline circulating LH <0.5 IU/L, <2 IU/L and <5 IU/L were associated with a 39.1%, 25.2% and 13.6% risk, respectively. LIMITATIONS, REASONS FOR CAUTION: The main limitation of the study is its retrospective design. WIDER IMPLICATIONS OF THE FINDINGS: This is the largest study of GnRH agonist trigger cycles only, since most of the previous research on the predictive value of basal LH levels was performed in dual trigger cycles. LH values should be measured prior to start of ovarian stimulation. In cases where they are immeasurable, suboptimal response to GnRH agonist trigger can be anticipated, and an individualized approach is warranted. STUDY FUNDING/COMPETING INTEREST(S): There was no funding and no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Popovic-Todorovic B, Santos-Ribeiro S, Drakopoulos P, et al. Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation. Hum Reprod. 2019. PMID: 31560740. doi:10.1093/humrep/dez132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。